Quest Diagnostics Incorporated Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | $1.86 | $1.86 | $1.86 |
| Q2 2024 | 6 | $2.33 | $2.33 | $2.33 |
| Q3 2024 | 5 | $2.26 | $2.27 | $2.26 |
| Q4 2024 | 12 | $2.15 | $2.22 | $2.19 |
| Q1 2025 | 10 | $2.12 | $2.24 | $2.19 |
| Q2 2025 | 9 | $2.43 | $2.65 | $2.56 |
| Q3 2025 | 9 | $2.38 | $2.60 | $2.51 |
| Q4 2025 | 9 | $2.33 | $2.55 | $2.46 |
| Q1 2026 | 8 | $2.30 | $2.51 | $2.42 |
| Q2 2026 | 8 | $2.70 | $2.94 | $2.84 |
| Q3 2026 | 8 | $2.57 | $2.81 | $2.71 |
| Q4 2026 | 8 | $2.49 | $2.71 | $2.61 |
Quest Diagnostics Incorporated Earnings Date And Information
Quest Diagnostics Incorporated last posted its earnings results on Tuesday, October 22nd, 2024. The company reported $2.3 earnings per share for the quarter, topping analysts' consensus estimates of $2.26 by $0.04. The company had revenue of 2.49 B for the quarter and had revenue of 9.25 B for the year. Quest Diagnostics Incorporated has generated $8 earnings per share over the last year ($7.52 diluted earnings per share) and currently has a price-to-earnings ratio of 20.8. Quest Diagnostics Incorporated has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based on prior year's report dates.
Quest Diagnostics Incorporated Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/23/2024 | Q3 2024 | $2.01 | $2.43 B | $2.49 B | ||
| 07/24/2024 | Q2 2024 | $2.05 | $2.39 B | $2.40 B | ||
| 04/24/2024 | Q1 2024 | $1.74 | $2.37 B | |||
| 02/22/2024 | Q4 2023 | $1.71 | $2.29 B | |||
| 10/25/2023 | Q3 2023 | $1.99 | $2.27 B | $2.30 B | ||
| 07/27/2023 | Q2 2023 | $2.09 | $2.26 B | $2.34 B | ||
| 04/28/2023 | Q1 2023 | $1.79 | $2.33 B | |||
| 02/21/2023 | Q4 2022 | $0.89 | $2.33 B | |||
| 10/21/2022 | Q3 2022 | $2.19 | $2.35 B | $2.49 B | ||
| 07/22/2022 | Q2 2022 | $1.99 | $2.34 B | $2.45 B | ||
| 04/22/2022 | Q1 2022 | $2.97 | $2.61 B | |||
| 02/28/2022 | Q4 2021 | $3.19 | $2.74 B | |||
| 10/22/2021 | Q3 2021 | $4.11 | $2.45 B | $2.77 B | ||
| 07/23/2021 | Q2 2021 | $5.05 | $2.39 B | $2.55 B | ||
| 04/23/2021 | Q1 2021 | $3.52 | $2.72 B | |||
| 02/22/2021 | Q4 2020 | $4.28 | $3.00 B | |||
| 10/23/2020 | Q3 2020 | $4.20 | $2.72 B | $2.79 B | ||
| 07/24/2020 | Q2 2020 | $1.38 | $1.69 B | $1.83 B | ||
| 05/04/2020 | Q1 2020 | $0.74 | $1.82 B | |||
| 02/20/2020 | Q4 2019 | $1.88 | $1.93 B |
Quest Diagnostics Incorporated Earnings: Frequently Asked Questions
-
When is Quest Diagnostics Incorporated's earnings date?
Quest Diagnostics Incorporated has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based off last year's report dates.
-
Did Quest Diagnostics Incorporated beat their earnings estimates last quarter?
In the previous quarter, Quest Diagnostics Incorporated (:DGX) reported $2.3 earnings per share (EPS) to beat the analysts' consensus estimate of $2.26 by $0.04.
-
How can I listen to Quest Diagnostics Incorporated's earnings conference call?
The conference call for Quest Diagnostics Incorporated's latest earnings report can be listened to online.
-
How can I read Quest Diagnostics Incorporated's conference call transcript?
The conference call transcript for Quest Diagnostics Incorporated's latest earnings report can be read online.
-
How much revenue does Quest Diagnostics Incorporated generate each year?
Quest Diagnostics Incorporated (:DGX) has a recorded annual revenue of $9.25 B.
-
How much profit does Quest Diagnostics Incorporated generate each year?
Quest Diagnostics Incorporated (:DGX) has a recorded net income of $9.25 B. Quest Diagnostics Incorporated has generated $7.59 earnings per share over the last four quarters.
-
What is Quest Diagnostics Incorporated's price-to-earnings ratio?
Quest Diagnostics Incorporated (:DGX) has a price-to-earnings ratio of 20.8 and price/earnings-to-growth ratio is 0.41.
